Table 4 Univariate and multivariate analyses for survival outcomes in patients with high-risk factors

Histology

Non-SCC vs. SCC

2.040

0.932–4.464

0.074

2.230

0.961–5.175

0.062

1.658

0.453–6.060

0.445

1.246

0.321–4.827

0.751

2009 FIGO stage

IIA vs. IB

0.800

0.356–1.797

0.588

1.903

0.637–5.684

0.249

Para-aortic lymphadenectomy

Yes vs. No

0.934

0.437–1.995

0.860

1.559

0.523–4.642

0.426

Pathologic cervical tumor size^*

≥40 vs. < 40 mm

1.368

0.651–2.874

0.409

1.514

0.692–3.309

0.299

1.716

0.528–5.578

0.369

1.289

0.368–4.515

0.691

Parametrial invasion

Yes vs. No

1.367

0.658–2.838

0.402

2.348

1.047–5.264

0.038

4.896

1.085–22.094

0.039

9.662

1.841–50.712

0.007

Lymph node metastasis

Yes vs. No

3.077

0.933–10.150

0.065

5.198

1.450–18.635

0.011

4.122

0.536–31.725

0.174

10.198

1.160–89.675

0.036

Surgical approach

MIS vs. Open surgery

2.072

1.011–4.247

0.047

3.406

1.558–7.448

0.002

1.030

0.312–3.400

0.961

3.029

0.775–11.833

0.111

Additional chemotherapy

Yes vs. No

1.193

0.579–2.456

0.632

1.138

0.529–2.448

0.742

2.062

0.671–6.335

0.206

2.065

0.622–6.857

0.236